Yin T, Qi L, Zhou Y, Kong F, Wang S, Yu M
J Int Med Res. 2022; 50(9):3000605221110075.
PMID: 36112929
PMC: 9483961.
DOI: 10.1177/03000605221110075.
Na H, Choe J, Shin S, Kim H, Han J, Kim H
PLoS One. 2019; 14(10):e0224247.
PMID: 31644584
PMC: 6808439.
DOI: 10.1371/journal.pone.0224247.
Ma X, Zhong Y, Zheng Y, Jiang J, Wang Y
Cancer Med. 2018; 7(9):4284-4295.
PMID: 30019388
PMC: 6144247.
DOI: 10.1002/cam4.1674.
Desoky T, Hassan M, Fayed H, Sakhr H
Neuropsychiatr Dis Treat. 2017; 13:2397-2403.
PMID: 28979127
PMC: 5608227.
DOI: 10.2147/NDT.S146152.
Duggal R, Rana A, Vaid A, Sood N, Handa K
Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):152-5.
PMID: 27408379
PMC: 4925542.
DOI: 10.1007/s12288-015-0629-8.
Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses.
Badial P, Tallmadge R, Miller S, Stokol T, Richards K, Borges A
Clin Vaccine Immunol. 2015; 22(11):1133-45.
PMID: 26311245
PMC: 4622111.
DOI: 10.1128/CVI.00374-15.
The PGE2/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection.
Arcanjo A, LaRocque-de-Freitas I, Rocha J, Zamith D, Costa-da-Silva A, Nunes M
PLoS One. 2015; 10(5):e0124888.
PMID: 25933287
PMC: 4416734.
DOI: 10.1371/journal.pone.0124888.
Immunological cells and functions in Gaucher disease.
Pandey M, Grabowski G
Crit Rev Oncog. 2013; 18(3):197-220.
PMID: 23510064
PMC: 3661296.
DOI: 10.1615/critrevoncog.2013004503.
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.
Pahl M, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri N
Nephrol Dial Transplant. 2009; 25(1):205-12.
PMID: 19684120
PMC: 2796898.
DOI: 10.1093/ndt/gfp397.
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
McCARTHY B, Boyle E, Wang X, Guzowski D, Paul S, Catera R
Mol Med. 2008; 14(9-10):618-27.
PMID: 18633450
PMC: 2464573.
DOI: 10.2119/2008.00061.McCarthy.
Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: application to nonstructural protein 1 in a model of Japanese encephalitis virus.
Konishi E, Kitai Y, Kondo T
Clin Vaccine Immunol. 2007; 15(1):88-94.
PMID: 18032598
PMC: 2223849.
DOI: 10.1128/CVI.00347-07.
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.
Yan X, Albesiano E, Zanesi N, Yancopoulos S, Sawyer A, Romano E
Proc Natl Acad Sci U S A. 2006; 103(31):11713-8.
PMID: 16864779
PMC: 1518806.
DOI: 10.1073/pnas.0604564103.
Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
Robertson M, Schacterle R, Mackin G, Wilson S, Bloomingdale K, Ritz J
Clin Exp Immunol. 2005; 141(2):326-32.
PMID: 15996197
PMC: 1809442.
DOI: 10.1111/j.1365-2249.2005.02833.x.
B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.
Goodyear C, Silverman G
Springer Semin Immunopathol. 2005; 26(4):463-84.
PMID: 15633015
DOI: 10.1007/s00281-004-0190-2.
Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.
Zuckerman E, Kessel A, Slobodin G, Sabo E, Yeshurun D, Toubi E
J Virol. 2003; 77(19):10432-6.
PMID: 12970428
PMC: 228427.
DOI: 10.1128/jvi.77.19.10432-10436.2003.
The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation.
Inoue H, Yasuda Y, Hattori K, Shimizu T, Matsumoto M, Yabe M
Int J Hematol. 2003; 77(4):399-407.
PMID: 12774932
DOI: 10.1007/BF02982652.
Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.
Cerutti A, Zan H, Kim E, Shah S, Schattner E, Schaffer A
J Immunol. 2002; 169(11):6594-603.
PMID: 12444172
PMC: 4625981.
DOI: 10.4049/jimmunol.169.11.6594.
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
Gurrieri C, McGuire P, Zan H, Yan X, Cerutti A, Albesiano E
J Exp Med. 2002; 196(5):629-39.
PMID: 12208878
PMC: 2194006.
DOI: 10.1084/jem.20011693.
Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K
Clin Exp Immunol. 2002; 128(2):353-8.
PMID: 11985527
PMC: 1906389.
DOI: 10.1046/j.1365-2249.2002.01844.x.
Immunoglobulin in the control of complement action.
Frank M, Miletic V, Jiang H
Immunol Res. 2001; 22(2-3):137-46.
PMID: 11339351
DOI: 10.1385/IR:22:2-3:137.
